The univariate analyses of log-rank tests and the PH model for the outcome determined that the following variables were associated with the risk of death due to disease, at the significance level of 0.05: (1) abstinence status, (2) stage of disease, (3) hormone receptor status, (4) HER2 status, (5) neoadjuvant chemotherapy, (6) adjuvant chemotherapy, (7) adjuvant hormonal therapy, (8) adjuvant radiotherapy, (9) tumor grade, (10) tumor histology, (11) lymphatic invasion, (12) vascular invasion, (13) surgery type, and (14) stage IV de-novo disease. The gene discussed is NR4A1; the disease is neoplasm.